Second edition

20.qxd 3/10/08 9:58 AM Page 651
Mitchell C. Successful treatment of chronic delusional
parasittosis. Br J Psychiatry 1989; 155:556–7.
Mitchell PB, Wilhelm K, Parker G et al. The clinical features of
bipolar depression: a comparison with matched major
depressive patients. J Clin Psychiatry 2001; 62:212–16.
Modigh K, Westberg P, Eriksson E. Superiority of clomipramine
over imipramine in the treatment of panic disorder: a placebocontrolled
trial. J Clin Psychopharmacol 1992; 12:251–61.
Montgomery SA, Tobias K, Zornberg GL et al. Efficacy and safety
of pregabalin in the treatment of generalized anxiety disorder:
a 6-week multicenter, randomized, double-blind, placebocontrolled
comparison of pregabalin and venlafaxine. J Clin
Psychiatry 2006; 67:771–82.
Morrison JR. Catatonia: retarded and excited types. Arch Gen
Psychiatry 1973; 28:39–41.
Moses EL, Mallinger AG. St. John’s wort: three cases of possible
mania induction. J Clin Psychopharmacol 2000; 20:115–17.
Mueser KT, Bellack AS, Brady EU. Hallucinations in schizophrenia.
Acta Psychiatr Scand 1990; 82:26–9.
Munoz RA. Postpartum psychosis as a discrete entity. J Clin
Psychiatry 1985; 46:182–4.
Murray RM. Neurodevelopmental schizophrenia: the rediscovery of
dementia praecox. Br J Psychiatry 1994; 165(suppl. 25):6–12.
Nappi RE, Petraglia F, Luisi S et al. Serum allopregnanolone in
women with postpartum ‘blues’. Obstet Gynecol 2001; 97:77–80.
Nemeroff CB, Widerlow E, Bissete G et al. Elevated concentrations
of CSF corticotropin-releasing factor-like immunoreactivity in
depressed patients. Science 1984; 226:1342–4.
Newman SC, Bland RC. A population-based family study of DSM-III
generalized anxiety disorder. Psychol Med 2006; 36:1275–81.
Ninan PT, Koran LM, Kiev A et al. High-dose sertraline strategy for
nonresponders to acute treatment of obsessive-compulsive
disorder; a multicenter double-blind trial. J Clin Psychiatry
2006; 67:15–22.
Nisita C, Petracca A, Akiskal HS et al. Delimitation of generalized
anxiety disorder: clinical comparisons with panic and major
depressive disorder. Compr Psychiatry 1990; 31:409–15.
Nopoulos P, Torres I, Flaun M et al. Brain morphology in firstepisode
schizophrenia. Am J Psychiatry 1995; 152:1721–3.
Nordahl TE, Semple WE, Gross M et al. Cerebral glucose metabolic
differences in patients with panic disorder.
Neuropsychopharmacology 1990; 3:261–72.
North CS, Smith EM, Spitznagel EL. Posttraumatic stress disorder
in survivors of a mass shooting. Am J Psychiatry 1994;
151:82–8.
Noyes R, Crowe RR, Harris EL et al. Relationship between panic
disorder and agoraphobia. A family study. Arch Gen Psychiatry
1986; 43:227–32.
Noyes R, Clarkson C, Crow RR et al. A family study of generalized
anxiety disorder. Am J Psychiatry 1987; 144:1019–24.
Noyes R, Burows GD, Reich JH et al. Diazepam versus alprazolam
for the treatment of panic disorder. J Clin Psychiatry 1996;
57:349–55.
Nutt DJ, Glue P, Lawson C et al. Flumazenil provocation of panic
attacks: evidence for altered benzodiazepine receptor
sensitivity in panic disorder. Arch Gen Psychiatry 1990;
47:917–25.
References 651
Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the
treatment of panic disorder: a randomized, double-blind,
placebo-controlled study. Br J Psychiatry 1995; 167:374–9.
Opjordsmoen R, Rettersol N. Delusional disorder: the predictive
validity of the concept. Acta Psychiatr Scand 1991; 84:250–4.
Page AC. Distinguishing panic disorder and agoraphobia from
social phobia. J Nerv Ment Dis 1994; 182:611–17.
Palatnik A, Frolov K, Fux M et al. Double-blind, controlled,
crossover trial of inositol versus fluvoxamine for the treatment
of panic disorder. J Clin Psychopharmacol 2001; 21:335–9.
Pande AC, Davidson JRT, Jefferson JW et al. Treatment of social
phobia with gabapentin: a placebo-controlled study. J Clin
Psychopharmacol 1999; 19:341–8.
Pande AC, Feltner DE, Jefferson JW et al. Efficacy of the novel
anxiolytic pregabalin in social anxiety disorder: a placebocontrolled,
multicenter study. J Clin Psychopharmacol 2004;
24:141–9.
Pauls DL, Alsobrook JP, Goodman W et al. A family study of
obsessive-compulsive disorder. Am J Psychiatry 1995;
152:76–84.
Pearlstein TB, Stone AB. Long-term fluoxetine treatment of late
luteal phase dysphoric disorder. J Clin Psychiatry 1994;
55:332–5.
Pearlstein TB, Stone AB, Lund SA et al. Comparison of fluoxetine,
bupropion, and placebo in the treatment of premenstrual
dysphoric disorder. J Clin Psychopharmacol 1997; 17:261–6.
Pecknold JC, Swinson RP, Krich K et al. Alprazolam in panic
disorder and agoraphobia: results from a multicenter trial. III.
Discontinuation effects. Arch Gen Psychiatry 1988; 45:429–36.
Perani D, Colombo C, Bressi S et al. [18F]FDG PET study in
obsessive-compulsive disorder: a clinical/metabolic correlation
study after treatment. Br J Psychiatry 1995; 166:244–50.
Perlis ML, Smith MT, Orff HJ et al. The effects of orally
administered cholinergic agonists on REM sleep in major
depression. Biol Psychiatry 2002; 51:457–62.
Perlmutter SJ, Leitman SF, Garvey MA et al. Therapeutic plasma
exchange and intravenous immunoglobulin for obsessivecompulsive
disorder and tic disorders in childhood. Lancet
1999; 354:1153–8.
Pfohl B, Vaquez N, Nasrallah H. Unipolar vs. bipolar mania: a
review of 247 patients. Br J Psychiatry 1982; 141:453–8.
Pigott TA, Pato MT, Bernstein SE et al. Controlled comparisons of
clomipramine and fluoxetine in the treatment of obsessivecompulsive
disorder: behavioral and biological results. Arch
Gen Psychiatry 1990; 47:926–32.
Pitman RK, Orr SP, Forgue DF et al. Psychophysiologic assessment
of post-traumatic stress disorder imagery in Vietnam combat
veterans. Arch Gen Psychiatry 1987; 44:970–5.
Pitt B. Maternity blues. Br J Psychiatry 1973; 122:431–3.
Pohl R, Yeragani VK, Balon R et al. Isoproterenol-induced panic
attacks. Biol Psychiatry 1988; 24:891–902.
Pollack MH, Zaninelli R, Goddard A et al. Paroxetine in the
treatment of generalized anxiety disorder: results of a
placebo-controlled, flexible-dosage trial. J Clin Psychiatry
2001; 62:350–7.
Pope HG, Lipinski JF, Cohen BM et al. ‘Schizoaffective disorder’, an
invalid diagnosis? A comparison of schizoaffective disorder,